Proto Labs Inc — Operating Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5e64bbe6-4501-42ad-9ac9-73304442fb95/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $25.1M | 2025-01-01 – 2025-12-31 | evidence 0001443669-26-000010 |
| FY 2024 | $19.9M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-007052 |
| FY 2023 | $28.2M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-005285 |
| FY 2022 | $-98.0M | 2022-01-01 – 2022-12-31 | evidence 0001437749-23-003930 |
| FY 2021 | $40.3M | 2021-01-01 – 2021-12-31 | evidence 0001437749-22-003779 |
| FY 2020 | $59.8M | 2020-01-01 – 2020-12-31 | evidence 0001437749-21-003413 |
| FY 2019 | $79.9M | 2019-01-01 – 2019-12-31 | evidence 0001437749-20-003547 |
| FY 2018 | $88.9M | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-003141 |
| FY 2017 | $72.2M | 2017-01-01 – 2017-12-31 | evidence 0001437749-18-003222 |
| FY 2016 | $61.8M | 2016-01-01 – 2016-12-31 | evidence 0001437749-17-002947 |
| FY 2015 | $67.1M | 2015-01-01 – 2015-12-31 | evidence 0001437749-16-026114 |
| FY 2014 | $60.5M | 2014-01-01 – 2014-12-31 | evidence 0001437749-15-003620 |
| FY 2013 | $51.3M | 2013-01-01 – 2013-12-31 | evidence 0001437749-14-003075 |
| FY 2012 | $38.7M | 2012-04-01 – 2013-03-31 | evidence 0001193125-13-206525 |
| FY 2011 | $26.9M | 2011-01-01 – 2011-12-31 | evidence 0001193125-13-121462 |
| FY 2010 | $15.9M | 2010-01-01 – 2010-12-31 | evidence 0001193125-13-121462 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).